CD5 positive B-ALL, a uniquely aggressive subcategory of B-ALL? A case report and brief review of the literature
PEDIATRIC BLOOD & CANCER
Authors: Staley, Elizabeth M.; Feldman, Alexander Z.; Koenig, Richard G.; Hill, Benjamin
Abstract
CD5 antigen expression in B-cell acute lymphoblastic leukemia (B-ALL) is exceptionally rare. There are six detailed case reports in the literature, with only 16 cases described. Case series analyzing the frequency of aberrant B-ALL immunophenotypes suggest that this variant may occur in as little as 2-4.5% of all B-ALL cases, with one series having no CD5(+) positive cases. Herein we report a case of CD5(+) B-ALL in a 15-year-old female, and review the previously reported cases. As limited information is available, more data from prospective clinical trials are required to determine whether CD5 positivity portends a poorer prognosis.
Secondary Cutaneous Dissemination of Peripheral T-Cell Lymphoma With T-Follicular Helper Phenotype as a Patient's Fourth Primary Malignancy
AMERICAN JOURNAL OF DERMATOPATHOLOGY
Authors: Beksac, Burcu; Acar, Emine M.; Ilter, Nilsel; Ertunc, Onur; Akyurek, Nalan
Abstract
Peripheral T-cell lymphomas expressing follicular helper T-cell (T-FH) markers have recently been identified. Although this type of lymphomas consist of malignant proliferation of T-cells, they may also exhibit B-cell clonality. We report a case of a 72-year-old woman with multiple erythematous to violaceous nonscaling plaques and tumors on her trunk. Histopathological analysis revealed a dense infiltration of medium-to-large-sized atypical cells throughout the entire dermis. The result of immunohistochemical analysis showed that the infiltrating T-cells expressed programmed death-1 (PD-1), CD10, Bcl-6, CD3, CD4, CD2, and CD5. The infiltrate also contained scattered atypical large B-cells. Based on the clinical appearance and the histopathological findings, we diagnosed the patient with secondary cutaneous dissemination of peripheral T-cell lymphoma with expression of a T-follicular helper phenotype.